Potential Cardiovascular Blockbuster Inclisiran Among New Filings At EMA
The European Medicines Agency has agreed to review pan-EU marketing applications for a number of new medicines.
The European Medicines Agency has agreed to review pan-EU marketing applications for a number of new medicines.